Per the Mast Cell Disease Society's December 31 email, the nonprofit has, among many other contributions,
- "[a]warded $60,000 in partnership with the Academy of Allergy, Asthma, and Immunology (AAAAI) to Dr. Dwyer with Brigham and Women's Hospital, Boston, MA to advance "single-cell characterization of cutaneous mast cells in mastocytosis and hereditary alpha-tryptasemia."
This is exciting, because it brings yet another research hospital into the forefront of HαTs research.
"Karen Smith-Will, C, owns a consulting company that has gotten 10,000 hits on its website tryptasemia.com and tryptasemia.org. 'This website helps patients with Hereditary Alpha Tryptasemia syndrome hats to find the resources they need, especially human connections via stories," she said. 'About 1% of people with Caucasian genes have the disorder, so HαTs is not particularly rare. However, fewer than a thousand people in the world have been diagnosed because this genetic disorder has only been identified since 2015. Karen and several of her extended family members were diagnosed in 2018.'"
University of Richmond Magazine, Spring/Summer, 2021, p. 66.